Paroxetine
Anxiety disorders for which Seroxat is used include: obsessive-compulsive disorder (recurring, obsessive thoughts with uncontrolled behavior), panic disorder with or without agoraphobia (panic attacks, including those caused by agoraphobia, which is a fear of open spaces), social phobia (fear or avoidance of social situations), post-traumatic stress disorder (anxiety caused by a traumatic event), generalized anxiety disorder (generalized feeling of anxiety or nervousness).
Seroxat belongs to a group of medicines called selective serotonin reuptake inhibitors (SSRIs). It is not fully understood how Seroxat and other SSRIs work, but they may increase the levels of serotonin in the brain. Proper treatment of depression and anxiety disorders is important for the patient to feel better.
If the answer is YES to any of the above questionsand the patient has not yet consulted their doctor, they should go back to their doctorand ask how to take Seroxat.
Seroxat should not be used in children and adolescents under 18 years old.Patients under 18 years old are at increased risk of side effects, such as suicidal attempts, suicidal thoughts, and hostility (especially aggression, rebellious behavior, and signs of anger) when taking Seroxat. If the doctor has prescribed Seroxat to a patient under 18 years old and there are doubts, the patient should contact their doctor. If these symptoms occur or worsen while taking Seroxat, the patient should inform their doctor. Additionally, there is currently no data on the long-term safety of Seroxat regarding growth, maturation, and cognitive and behavioral development in this age group.
In studies of Seroxat in patients under 18 years old, common side effects that occurred with a frequency of less than 1 in 10 were: increased suicidal thoughts and attempts, intentional self-harm, hostility, aggressive behavior, or unfriendly behavior, loss of appetite, tremors, sweating, and increased activity (excessive energy), restlessness, emotional instability (including tearfulness and mood changes), and unusual bruising or bleeding (such as nosebleeds).
These studies also showed that such symptoms occurred, although less frequently, in children and adolescents taking placebo (sugar pills) instead of Seroxat.
Some patients under 18 years old in these studies experienced withdrawal symptoms when stopping Seroxat. These symptoms were very similar to those observed in adults after stopping Seroxat (see section 3). Additionally, in patients under 18 years old, abdominal pain, restlessness, and emotional instability (including tearfulness, mood changes, self-harm, suicidal thoughts, and attempts) also occurred frequently (with a frequency of less than 1 in 10).
In patients with depression and/or anxiety disorders, suicidal thoughts or self-harm may sometimes occur. They may be more frequent at the start of antidepressant treatment, as it may take some time, usually about two weeks, for the medicines to start working, and sometimes even longer.
In patientssuch thoughts may occur more frequently:
It may be helpful for the patient to inform a relative or friendabout their depression or anxiety disorder and ask them to read this leaflet. The patient may ask them to tell them if they notice that their depression or anxiety disorder is getting worse or if they notice any worrying changes in their behavior.
In some patients taking Seroxat, a condition called akathisia may develop. They will feel anxious and unable to sit or stand still. In other patients, a condition called serotonin syndrome or neuroleptic malignant syndrome may occur, in which patients have some or all of the following symptoms: feeling very agitated or irritable, confused, anxious, hot, sweaty, trembling, shaking, hallucinations (seeing or hearing strange things), stiff muscles, sudden muscle contractions, or fast heartbeat. These symptoms may worsen, leading to loss of consciousness. If the patient notices any of these symptoms, they should contact their doctor. More information about these or other side effects of Seroxat can be found in section 4.
Medicines like Seroxat (SSRIs) may cause sexual function disorders (see section 4). In some cases, these symptoms have persisted after stopping treatment.
Some medicines may affect the action of Seroxat or increase the risk of side effects. Seroxat may also affect the action of other medicines. These medicines include:
If the patient is currently taking or has recently taken any of the above medicines, and has not yet discussed this with their doctor, they should contact their doctor againand ask how to proceed. The dose of the medicine may need to be changed or a different medicine may need to be taken.
have recently taken, as well as any medicines they plan to take, including those that are available without a prescription.
The patient should not drink alcohol while taking Seroxat. Alcohol may increase the symptoms of the disease or side effects. Taking Seroxat in the morning, with food, reduces the likelihood of nausea.
If the patient is pregnant or breastfeeding, or thinks they may be pregnant or plans to have a baby, they should consult their doctor or pharmacist before taking this medicine.
There are reports that children whose mothers took Seroxat during the first few months of pregnancy had congenital malformations, particularly heart defects. In the general population, about 1 in 100 children is born with a heart defect. This number increases to 2 in 100 children if the mother takes Seroxat. The doctor will decide together with the patient whether it is better for the patient to switch to a different medicine or gradually stop taking Seroxat during pregnancy. In some cases, the doctor may also suggest that it is better for the patient to continue taking Seroxat.
Seroxat.Taking Seroxat at the end of pregnancy may increase the risk of severe bleeding from the vagina, which occurs shortly after delivery, especially if the patient has a history of bleeding disorders. If the patient is taking Seroxat, they should inform their doctor or midwife so that they can provide appropriate advice. Medicines like Seroxat, when taken during pregnancy, especially in the last few months, may increase the risk of a condition called persistent pulmonary hypertension in the newborn (PPHN).
In PPHN, the blood pressure in the blood vessels between the heart and lungs is too high. If the patient takes Seroxat during the last 3 months of pregnancy, the newborn may also experience other symptoms, usually within the first 24 hours after birth, including:
Seroxat may pass into breast milk in very small amounts.If the patient is taking Seroxat, they should consult their doctor before breastfeeding. The doctor, together with the patient, may decide that the patient can breastfeed while taking Seroxat.
In animal studies, paroxetine has been shown to reduce sperm quality. This could theoretically affect fertility, but the impact on human fertility has not been determined yet.
Possible side effects of Seroxat include dizziness, disorientation, drowsiness, and vision disturbances. If the patient experiences any of these side effects, they should not drive or operate machinery.
This medicine contains less than 1 mmol (23 mg) of sodium per tablet, which means it is essentially 'sodium-free'.
This medicine should always be taken exactly as prescribed by the doctor.If the patient has any doubts, they should consult their doctor or pharmacist.
Sometimes taking one tablet does not ensure that the patient takes the full recommended dose of the medicine. The following table shows how many Seroxat tablets the patient should take for each dose.
10 mg
half a tablet
20 mg
one tablet
30 mg
one and a half tablets
40 mg
two tablets
50 mg
two and a half tablets
60 mg
three tablets
Usual doses for different conditions are given below.
The doctor will advise the patient on which dose to start with.Most patients start to feel better after a few weeks. If the patient does not feel better after this time, they should consult their doctor. The doctor may decide to gradually increase the dose by 10 mg until the maximum daily dose is reached.
The doctor will discuss with the patient how long they should take the tablets. Treatment may last for several months or even longer.
The maximum dose for patients over 65 years old is 40 mg per day.
The doctor may recommend a lower dose of Seroxat for patients with liver or severe kidney disease.
The patient should never take more tablets than prescribed by the doctor.If the patient (or someone else) has taken too many Seroxat tablets, they should immediately inform their doctor or contact the nearest emergency department. They should show them the packaging of the tablets.
As a result of overdosing on Seroxat, the patient may experience side effects described in section 4: Possible side effectsor the following symptoms: fever, involuntary muscle contractions.
The medicine should be taken at the same time every day.
If the patient misses a dose and remembers before going to bed, they should take it immediately. The next day, they should take the dose as usual.
If the patient remembers in the night or the next day that they missed a dose, they should not take the missed dose. The patient may experience withdrawal symptoms, but they should resolve quickly after taking the next dose at the usual time.
The patient should not take a double dose to make up for the missed dose.
Initial dose | Recommended daily dose | Maximum daily dose | |
Depression | 20 mg | 20 mg | 50 mg |
Obsessive-compulsive disorder | 20 mg | 40 mg | 60 mg |
Panic disorder | 10 mg | 40 mg | 60 mg |
Social phobia | 20 mg | 20 mg | 50 mg |
Post-traumatic stress disorder | 20 mg | 20 mg | 50 mg |
Generalized anxiety disorder | 20 mg | 20 mg | 50 mg |
Seroxat does not relieve symptoms immediately -all antidepressant medicines take some time to start working. Some patients start to feel better after a few weeks, and others later. Some patients taking antidepressants feel worse before they start to feel better. If the patient does not feel better after a few weeks of treatment, they should consult their doctor for advice. The doctor should recommend that the patient have a follow-up visit after a few weeks of starting to take the medicine for the first time. The patient should inform their doctor if they do not start to feel better.
When stopping Seroxat, the doctor will help the patient to gradually reduce the dose over a few weeks or months - this should reduce the risk of withdrawal symptoms. One way to do this is to gradually reduce the dose of Seroxat by 10 mg per week. In most patients, withdrawal symptoms are mild and resolve on their own within two weeks. In some patients, symptoms may be more severe or may last longer.
If the patient experiences withdrawal symptomsafter stopping Seroxat, the doctor may decide that the patient should stop taking the medicine more slowly. If the symptoms are severe during the withdrawal of Seroxat, the patient should contact their doctor. The doctor may recommend restarting the tablets and stopping them more slowly.
Studies have shown that 3 in 10 patients notice one or more withdrawal symptoms when stopping Seroxat. Some of these symptoms occur more frequently than others.
In case of further doubts about taking this medicine, the patient should consult their doctor or pharmacist.
Like all medicines, Seroxat can cause side effects, although not everybody gets them.
Side effects are more common during the first few weeks of taking Seroxat.
It may be necessary to contact the doctor or the nearest emergency department immediately.
feeling very agitated or irritable, confused, anxious, hot, sweaty, trembling, shaking, hallucinations (seeing or hearing strange things), stiff muscles, sudden muscle contractions, or fast heartbeat. These symptoms may worsen, leading to loss of consciousness. If such symptoms occur, the patient should contact their doctor;
Side effects with unknown frequency(frequency cannot be estimated from the available data)
Side effects with unknown frequency(frequency cannot be estimated from the available data):
Some patients taking Seroxat may experience buzzing, hissing, whistling, or other persistent noises in the ears (tinnitus) during treatment.
Patients taking medicines like Seroxat have been observed to have an increased risk of fractures.
If the patient experiences any side effects, including any side effects not listed in this leaflet, they should tell their doctor or pharmacist. Side effects can be reported directly to the Department of Drug Safety, Ministry of Health, via the online reporting system at [website URL]. By reporting side effects, more information can be collected on the safety of this medicine.
The medicine should be kept out of sight and reach of children.
The patient should not use this medicine after the expiry date stated on the packaging. The expiry date refers to the last day of the month.
The patient should not store the medicine above 30°C.
The patient should store the medicine in its original packaging to protect it from light.
If the patient is taking half-tablets, they should be careful to store them in the medicine packaging.
Medicines should not be disposed of via wastewater or household waste. The patient should ask their pharmacist how to dispose of medicines that are no longer needed. This will help protect the environment.
The active substance of Seroxat is paroxetine (20 mg) in the form of paroxetine hydrochloride hemihydrate.
Other ingredients of the medicine are:
Tablet core: calcium hydrogen phosphate dihydrate, magnesium stearate, sodium carboxymethylcellulose (type A).
Coating: Opadry White YS-1R-7003: hypromellose, titanium dioxide (E 171), macrogol 400, polysorbate 80.
Seroxat 20 mg, coated tablets - white, oval, biconvex, coated tablets with the inscription "20" on one side and a score line on the other side.
Each pack of Seroxat 20 mg coated tablets contains 30 tablets in child-resistant blisters.
For more detailed information, the patient should contact the marketing authorization holder or the parallel importer.
GlaxoSmithKline (Ireland) Limited
12 Riverwalk, Citywest Business Campus
Dublin 24
Ireland
DELPHARM POZNAŃ SPÓŁKA AKCYJNA
ul. Grunwaldzka 189
60-322 Poznań
Poland
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Medezin Sp. z o.o.
ul. Zbąszyńska 3
91-342 Łódź
Marketing authorization number in Romania, the country of export: 601/2008/02
Parallel import authorization number: 319/19
It may be helpful for the patient to contact a support group or patient organization, where they can find out more about their condition. The doctor can provide more detailed information.
[Information about the trademark]
Austria, Belgium, Cyprus, Czech Republic, Denmark, Estonia, Finland, Greece, Spain, Netherlands, Iceland, Ireland, Lithuania, Luxembourg, Latvia, Malta, Germany, Norway, Poland, Portugal, Slovakia, Slovenia, Sweden, United Kingdom (Northern Ireland), Italy | Seroxat |
France | Deroxat |
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.